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Background/aim: Endothelial dysfunction, tissue damage, inflammation, and microthrombosis are involved in the pathogenesis of
pulmonary hypertension (PH), which may be present as a complication of congenital heart diseases. This study aims to identify how
indicators of endothelial dysfunction (shear stress), tissue damage (brain natriuretic peptide and troponin T), inflammation (C-reactive
protein (CRP)), and microthrombosis (D-dimer and von Willebrand factor) are altered in children with congenital left-to-right shunting.
Materials and methods: This is a review of 25 children who developed PH due to congenital left-to-right shunting, 40 children who
underwent corrective surgery for congenital left-to-right shunting, and 40 healthy children.
Results: Serum brain natriuretic peptide (BNP), CRP, and CA-125 levels were significantly increased and shear stress was significantly
decreased in children with PH (P = 0.001, P = 0.044, P = 0.012, and P = 0.011). A BNP level of >225 pg/mL had a sensitivity of 95.3% and
specificity of 92.4%, whereas a CRP level of >2.2 IU/L had a sensitivity and specificity of 87.5%, and a CA-125 level of >35 IU/mL had
a sensitivity of 92.2% and a specificity of 90.4% for PH. Shear stress of <2.5 dyn/cm2 had a sensitivity of 84.8% and specificity of 92.9%.
Conclusions: A combination of BNP, CRP, CA-125, and shear stress might be used to predict the development of PH during follow-up
of children with congenital left-to-right shunting.
Key words: Biomarkers, child, congenital heart defects, pulmonary hypertension, shear strength

1. Introduction
Pulmonary hypertension (PH) is a chronic disease that
is characterized by progressive elevation in pulmonary
artery pressure. This disease may be present as an adverse
outcome of congenital heart diseases. The pathogenesis
of PH is primarily based on endothelial dysfunction
within pulmonary vasculature, which eventually leads
to medial thickening, intimal fibrosis, inflammation,
and microthrombosis. Tissue damage, inflammation,
and microthrombi formation are also involved in the
pathogenesis of PH (1–4).
Endothelial dysfunction within systemic circulation
occurs as a result of reduced wall shear stress. Wall shear
stress is a frictional force caused by a viscous drag along the
inner wall of the artery. This force modulates endothelial
function and, if altered, exerts a detrimental effect on
cardiovascular health. However, little is known about the
endothelium-specific response to wall shear stress within
the pulmonary vasculature and its role in the pathogenesis
and progression of pulmonary vascular diseases (5,6).
* Correspondence: drayhanpektas@hotmail.com
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Like shear stress, certain biomarkers can be used to
track the course of PH in children. For instance, brain
natriuretic peptide (BNP) and troponin T are indicators
of myocardial damage in the right ventricle, and they both
have diagnostic and prognostic value for children who have
PH. Similarly, C-reactive protein (CRP) is an indicator
of inflammation that might be used in the follow-up of
children with PH. On the other hand, D-dimer and von
Willebrand factor (vWF) might indicate the formation
of microthrombi in affected children. CA-125 might also
be considered as a potential biomarker for pediatric PH
because serum CA-125 levels correlate significantly with
pulmonary artery pressures (7–10).
This study aims to identify how these indicators of
endothelial dysfunction (shear stress), tissue damage
(BNP and troponin T), inflammation (CRP), and
microembolization (D-dimer and vWF) are altered in
children who have congenital heart diseases with left-to-right
shunting. The present study also aims to determine whether
these indicators can be used to predict the development of
PH in children with congenital left-to-right shunting.
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2. Materials and methods
This study has been approved by the Institutional Review
Board and the Ethical Committee of the Gazi University
Medical Faculty in Ankara, Turkey.
2.1. Study design
This is a cross-sectional study of 105 children (55 males,
50 females) who consecutively underwent consultation in
the Department of Pediatric Cardiology at Gazi University
Hospital between January 2012 and December 2013. The
study cohort consisted of three groups. Group I included
25 children who were diagnosed with secondary PH (in
relation to congenital heart diseases) according to the
catheter angiography findings. These children represented
neglected cases of congenital heart diseases with leftto-right shunting eventually diagnosed as Eisenmenger
syndrome. Group II consisted of 40 children who
underwent corrective surgery for congenital heart defects
with left-to-right shunting with no findings of PH based
on preoperative cardiac catheterization findings. Group
III was made up of 40 healthy children who had innocent
murmurs.
Children with acute or chronic bacterial and viral
infections, diabetes mellitus, systemic hypertension,
hypercholesterolemia, cardiomyopathies, valvular heart
diseases, coagulation disorders, hepatic dysfunction, and
renal failure were excluded.
2.2. Echocardiography examination
All patients were examined by a single experienced
echocardiographer who was blinded to the results of
the rheological measurements and who used twodimensional, pulse-wave Doppler echocardiography with
a 2.5-MHz transducer (Vivid 7, GE Vingmed Ultrasound,
Horten, Norway). The main pulmonary artery and the
left and right pulmonary artery branch diameters were
measured from the parasternal short axis at the level of
pulmonary artery bifurcation. Measurements were made
in the lateral–medial plane at end diastole.
2.3. Cardiac catheterization
Groups I and II consisted of 80 children who had congenital
heart diseases. These children underwent routine cardiac
catheterization and hemodynamic studies that were
performed with intravenous midazolam sedation. Pressure
measurements were recorded using fluid-filled catheters
connected to pressure transducers. Oxygen consumption
was estimated based on age, sex, and heart rate, according
to the LaFarge–Miettinen formula (11). Pulmonary (Qp)
and systemic (Qs) blood flow levels were calculated
using the Fick equation and indexed for body surface
area. The ratio of Qp/Qs blood flow, pulmonary (Rp) and
systemic (Rs) vascular resistance, and the Rp/Rs ratio were
calculated according to the standard formulas (12).

2.4. Rheological measurements
Rheological measurements were made by a single
experienced physiologist who was blinded to the clinical
and echocardiographic findings. Plasma viscosity was
determined in ethylenediaminetetraacetic acid plasma by
using a viscometer of the capillary type at 25 °C (Processer
Viscosity System 1, Lauda, Germany). Whole blood
viscosity was measured in ethylenediaminetetraacetic
acid plasma using a rotational viscometer (Contraves LS
30, Contraves, Switzerland) at a high shear rate (94.5/s)
at 37 °C (13). Peak and mean wall shear stress (dyn/cm2)
were calculated as previously described (13): shear stress
= 4 × blood viscosity (P) × blood velocity (cm/s)/internal
diameter of the main pulmonary artery (cm).
2.5. Laboratory studies
Serum concentrations of BNP, troponin T, D-dimer, and
CA-125 were measured by electrochemiluminescence
immunoassay (Elecsys 2010 Analyzer, Roche Diagnostics,
Mannheim, Germany). Serum uric acid level was
determined with radioimmunoassay (L X 20-Pro
Analyzer, Beckman Coulter, Woerden, the Netherlands).
Serum concentrations of CRP were measured by enzymelinked immunosorbent assay (Sigma-RAB0096 ELISA
kit, Sigma-Aldrich Corporation, Berlin, Germany). vWF
serum concentration was defined by latex immunoassay
(STA-Liatest vWF, Triolab AB, Gothenburg, Sweden).
Intraassay coefficients of variation were 5.3%, 3.8%, 7.8%,
6.2%, 5.0%, 5.0%, and 6.2% whereas interassay coefficients
of variation were 1.8%, 1.5%, 10.0%, 5.7%, 4.1%, 4.0%, and
5.7% for BNP, uric acid, troponin T, CRP, D-dimer, vWF,
and CA-125, respectively.
2.6. Statistical analysis
Collected data were analyzed with SPSS 18.0 (SPSS Inc.,
Chicago, IL, USA). Data were expressed as either mean
± standard deviation (range: minimum–maximum) or
numbers or percentages when appropriate. A Smirnov–
Kolmogorov test was used to test the distribution of
data. One-way ANOVA, Kruskal–Wallis, and Mann–
Whitney U tests were used for comparisons. A Bonferroni
adjustment was applied for all possible group comparisons,
controlling for type I errors. Probable relationships were
evaluated with a Pearson correlation test. The cutoff
levels for inflammatory biomarkers were determined
using a receiver operating characteristic (ROC) analysis.
Two-tailed P-values less than 0.05 were accepted to be
statistically significant. Since secondary pediatric PH
is a relatively rare disease, all of the children who were
diagnosed with this disease were enrolled in this study. The
sizes of the other two subgroups were based on the size of
the PH group. Therefore, a retrospective post hoc analysis
was carried out and it was determined that a cohort size
of 105 children (40 healthy controls, 40 children with
congenital heart defects, and 25 children with secondary
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PH) had 58.6% power to detect a difference at the 0.05
significance level.
3. Results
Table 1 summarizes the demographic and clinical
characteristics of the study cohort. Mean age was
significantly lower (P = 0.001), body weight was significantly
lower (P = 0.001), body height was significantly shorter (P
= 0.001), and body mass index was significantly lower (P =
0.001) in Group I than in Group II. When compared with
Group II, serum BNP, troponin T, CRP, and CA-125 levels
were significantly higher in Group I (P = 0.001, P = 0.042,
P = 0.044, and P = 0.001, respectively). Moreover, vascular
diameter was significantly larger, blood flow velocity was
significantly higher, and shear stress was significantly
lower in Group I (P = 0.032, P = 0.044, and P = 0.001,
respectively).
Table 2 lists the echocardiography and catheter
angiography findings of the reviewed children. Tricuspid
regurgitation velocity was significantly higher (P = 0.001),
tricuspid annular plane systolic excursion was significantly
lower (P = 0.001), and aortic annulus and pulmonary artery
diameters were significantly larger in the PH group (P =
0.004 and P = 0.001, respectively). Systolic right-ventricle

pressure, diastolic left-ventricle pressure, and systolic,
diastolic, and mean pulmonary artery pressures were also
significantly higher in these children (P = 0.001, P = 0.018,
P = 0.001, P = 0.003, and P = 0.001, respectively). On the
contrary, Qp and Qp/Qs were significantly lower and Rp
and Rp/Rs were significantly higher (P = 0.005, P = 0.022,
P = 0.026, and P = 0.001, respectively).
The Figure shows the receiver operating characteristic
curves for BNP, CRP, and CA-125. The cutoff values for
BNP, uric acid, troponin T, CRP, D-dimer, vWF, CA-125,
and shear stress were assigned as 305 pg/mL, 4.2 mg/dL,
0.025 ng/mL, 2.2 IU/L, 150 ng/mL, 160 IU/dL, 35 IU/mL,
and 2.5 dyn/cm2, respectively (Table 3).
Serum BNP levels significantly correlated with systolic
right-ventricle pressure (r = 0.411, P = 0.003), diastolic
right-ventricle pressure (r = 0.316, P = 0.005), and tricuspid
annular plane systolic excursion (r = –0.592, P = 0.001).
Serum CRP levels significantly correlated with ejection
fraction (r = –0.625, P = 0.001) and fractional shortening
(r = –0.466, P = 0.003). Serum CA-125 levels correlated
significantly with tricuspid annular plane systolic excursion
(r = –0.347, P = 0.003). Shear stress values correlated
significantly with ejection fraction (r = –0.572, P = 0.001)
and fractional shortening (r = –0.495, P = 0.001).

Table 1. Demographic and clinical characteristics of the study cohort.

Age (years)
Sex (male/ female)
Body height (cm)
Body weight (kg)
Body mass index (kg/m2)
Congenital heart defects
Ventricular septal defect
Patent ductus arteriosus
Atrioventricular septal defect
Atrial septal defect
Biochemical measurements
Brain natriuretic peptide (pg/mL)
Troponin T (ng/mL)
C-reactive protein (IU/L)
D-dimer (ng/mL)
von Willebrand factor (IU/dL)
CA-125 (IU/mL)
Rheological measurements
Vascular diameter (cm)
Blood flow velocity (c/s)
Shear stress (dyn/cm2)

Group I
(n = 25)

Group II
(n = 40)

Group III
(n = 40)

7.5 ± 5.7
12/13
(48.0%/52.0%)
110.8 ± 38.0
22.4 ± 16.8
14.6 ± 4.1

11.0 ± 0.6
20/20
(50%/50%)
134.2 ± 30.7
37.2 ± 10.5
20.7 ± 2.8

10.9 ± 0.9
23/17
(57.5%/42.5%)
145.4 ± 24.6
41.9 ± 17.8
19.9 ± 3.6

11 (44.0%)
7 (28.0%)
7 (28.0%)
-

21 (52.5%)
12 (30.0%)
5 (12.5%)
2 (5.0%)

870.1 ± 75.7
0.044 ± 0.022
3.2 ± 0.8
111.4 ± 42.7
189.3 ± 18.4
68.5 ± 2.3

316.7 ± 18.4
0.026 ± 0.001
1.9 ± 0.2
148.2 ± 21.6
167.4 ± 19.2
32.5 ± 1.5

12.5 ± 19.1
0.017 ± 0.007
1.8 ± 0.2
137.5 ± 24.1
132.5 ± 14.3
13.8 ± 0.7

0.001†*
0.042†*
0.044†*
0.642
0.610
0.001†*

2.6 ± 1.1
1.8 ± 0.7
2.8 ± 1.2

1.8 ± 0.5
1.6 ± 0.5
5.4 ± 0.6

1.5 ± 0.4
1.2 ± 0.2
7.1 ± 3.1

0.032†*
0.044†*
0.001†*

*P < 0.05 was accepted to be statistically significant.
†Statistical significance is detected between Group I and Group II.
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P
0.001†*
0.703
0.001†*
0.001†*
0.001†*
0.321
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Table 2. Echocardiography and catheter angiography findings of the study cohort.

Echocardiography findings
Ejection fraction (%)
Fractional shortening (%)
Tricuspid regurgitation velocity
Tricuspid annular plane systolic excursion
Aortic annulus diameter (mm)
Pulmonary artery annulus diameter (mm)
Right pulmonary artery diameter (mm)
Left pulmonary artery diameter (mm)
Catheter angiography findings
Systolic pulmonary artery pressure (mmHg)
Diastolic pulmonary artery pressure (mmHg)
Mean pulmonary artery pressure (mmHg)
Right atrium pressure (mmHg)
Systolic right-ventricle pressure (mmHg)
Diastolic right-ventricle pressure (mmHg)
Systolic left-ventricle pressure (mmHg)
Diastolic left-ventricle pressure (mmHg)
Pulmonary capillary wedge pressure (mmHg)
Pulmonary flow (m/s)
Systemic flow (m/s)
Pulmonary/systemic flow
Pulmonary vascular resistance (U/m2)
Systemic vascular resistance (U/m2)
Pulmonary/systemic vascular resistance

Group I
(n = 25)

Group II
(n = 40)

65.7 ± 11.5
35.6 ± 7.8
3.4 ± 1.0
2.6 ± 0.4
22.1 ± 3.8
24.3 ± 3.5
14.8 ± 3.4
15.7 ± 3.5

77.9 ± 8.0
38.9 ± 7.6
2.6 ± 0.6
2.8 ± 0.6
20.0 ± 4.2
21.8 ± 4.0
13.0 ± 2.8
13.5 ± 3.0

95.4 ± 23.3
47.5 ± 19.3
69.4 ± 20.0
5.2 ± 2.7
100.0 ± 20.9
4.6 ± 3.7
104.1 ± 21.5
6.7 ± 5.1
14.7 ± 4.5
5.1 ± 3.7
3.7 ± 0.7
1.5 ± 1.2
15.7 ± 10.3
21.8 ± 9.6
0.8 ± 0.6

31.0 ± 7.4
16.8 ± 13.5
17.9 ± 6.8
8.8 ± 8.2
40.2 ± 11.5
3.0 ± 1.8
103.5 ± 23.3
4.0 ± 2.8
7.0 ± 4.2
12.6 ± 6.2
4.8 ± 1.5
2.6 ± 0.6
6.4 ± 0.9
14.7 ± 5.5
0.1 ± 0.1

Group III
(n = 40)

77.7 ± 5.6
42.6 ± 7.8
2.0 ± 0.5
3.3 ± 0.6
19.3 ± 4.1
20.2 ± 4.2
12.8 ± 2.3
13.2 ± 3.1

P

0.656
0.377
0.001†*
0.001†*
0.004‡*
0.001†*
0.174
0.096
0.001*
0.003*
0.001*
0.591
0.001*
0.031
0.595
0.018*
0.064
0.005*
0.078
0.022*
0.026*
0.087
0.001*

*P < 0.05 was accepted to be statistically significant.
†Statistical significance is detected between Group I and Group III.
‡Statistical significance is detected between Group II and Group III.

4. Discussion
A biomarker can be defined as a parameter that is
objectively measured and evaluated as an indicator
of a normal biologic mechanism, pathogenic process,
or pharmacologic response. A variety of biomarkers
associated with inflammation, coagulation, and myocardial
stretching can be used to specify the progression of this
disease. Although several biomarkers are utilized to assess
and follow adults with PH, these markers have not been
validated in pediatric PH (9,10,14).
BNP has been addressed as the most frequently studied
biomarker in adults and children with PH (15,16). A
systematic review of 14 studies conducted on children
with PH showed that BNP had good prognostic value
and significantly correlated with mortality (17). It has
also been clarified that BNP levels differ significantly in
children with primary and secondary PH, but that BNP
values remain constant in the primary and secondary PH
groups (18).

In this study, serum BNP concentrations of the healthy
children and children with congenital heart diseases
were significantly lower than those of children with
Eisenmenger syndrome. Moreover, it was specified that
BNP values correlated significantly with systolic rightventricle pressure, diastolic right-ventricle pressure, and
tricuspid annular plane systolic excursion. These findings
imply that an increase in BNP reflects myocardial strain in
the right ventricles of children with congenital left-to-right
shunting.
CRP is an inflammatory marker that has been identified
as a prognostic marker in adults with Eisenmenger
syndrome. Elevated levels of CRP can be used to distinguish
individuals with increased cardiovascular morbidity and
mortality among apparently healthy subjects, patients
with coronary artery disease, or those with atherosclerosis
(19–21). It was found that serum concentrations of highly
sensitive CRP positively correlated with pulmonary artery
pressures in children with cystic fibrosis (22). Similarly, a
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Figure. ROC curves for BNP, CRP, CA-125, and shear stress show the predictive power of these parameters when
their cutoff values were assigned as 255 pg/mL, 2.2 IU/L, 35 IU/mL, and 2.5 dyn/cm2, respectively.

Table 3. Predictive power of biomarkers and shear stress.

Brain natriuretic peptide
Troponin T
C-reactive protein
D-dimer
von Willebrand factor
CA-25
Shear stress

Sensitivity

Specificity

Positive
predictive value

Negative
predictive value

χ2

P

96.1%
70.2%
88.0%
33.8%
51.5%
92.2%
84.8%

93.2%
28.3%
88.1%
59.6%
68.5%
90.4%
82.9%

82.8%
49.1%
81.7%
54.3%
68.5%
86.7%
85.3%

87.1%
46.2%
82.1%
51.5%
56.0%
84.5%
82.4%

62,596
146,460
73,380
137,030
166,455
55,132
37,040

0.001*
0.330
0.001*
0.225
0.318
0.001*
0.001*

*P < 0.05 was accepted to be statistically significant.

Turkish study found that that highly sensitive CRP levels
were significantly higher in children with secondary PH
when compared to healthy children (23).
This study was also able to detect a significant
increase in the serum CRP levels of children who were
diagnosed with Eisenmenger syndrome. In addition, CRP
values correlated significantly with ejection fraction and
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fractional shortening values. These findings suggest that
increased CRP might reflect the inflammatory changes
that proceed within the myocardial tissues of children
with congenital left-to-right shunting.
Serum CA-125 concentrations are markedly elevated
during myocardial infarction, and this increase correlates
significantly with systolic and mean pulmonary artery
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pressures. Patients with chronic obstructive pulmonary
disease also have high CA-125 levels, which significantly
correlate with systolic pulmonary artery pressure, rightventricular myocardial performance index, and fractional
area change. It has been reported that CA-125 is a valuable
biomarker in evaluating the efficiency of short-term
treatment for right heart failure, but the combination of
CA-125 and BNP might even be more valuable (24–26).
This study demonstrated a significant increase in serum
CA-125 levels of children with secondary PH. Additionally,
CA-125 values were found to correlate significantly with
right-ventricle functional area change and tricuspid
annular plane systolic excursion values. These findings
could be interpreted as a body of evidence for observing
increased CA-125 as an indicator of myocardial damage
in the right ventricles of children with congenital leftto-right shunting. Therefore, a combination of increased
BNP, CRP, and CA-125 concentrations could be used to
predict the development of PH during the clinical course
of congenital heart diseases with left-to-right shunting in
children.
The pathogenesis of PH is associated with a remodeling
process that increases vascular diameter, causes vascular
thickening, and induces vascular stiffness within pulmonary
tissues. It has been noted that patients with PH have
significantly reduced vascular distensibility and blood flow
in pulmonary vasculature (27). Truong et al. were the first to
report on the significant reduction in shear stress in children
and adolescents with PH (28). Schäfer et al. later concluded
that shear stress throughout the main pulmonary artery
is decreased in PH, and that this decrease is significantly
associated with catheter angiography findings (29). High
oscillatory shear index and low wall shear stress measured
with three-dimensional magnetic resonance imaging were
considered potential markers that could be used to predict
increased pulmonary artery pressure in patients with a high
index of suspicion for PH (30).

This work also reports that shear stress is significantly
reduced in the pulmonary vasculature of children with
secondary PH. The major reasons for this significant
reduction are an increase in vascular size and decrease
in vascular distensibility. This attenuation in shear
stress induces endothelial proliferation and medial
hypertrophy, eventually leading to right-ventricular
failure. Accordingly, decreased shear stress may be used
to predict the emergence of PH in association with
congenital left-to-right shunting.
In conclusion, it has been well established that BNP,
CRP, and shear stress have prognostic value in adults
with Eisenmenger syndrome, whereas CA-125 reflects
cardiac functions in adults with heart failure. This study
points out that BNP, CRP, and CA-125 are significantly
increased while shear stress is significantly decreased
in children with Eisenmenger syndrome. Therefore, the
combination of BNP, CRP, CA-125, and shear stress can
be used to predict the development of PH during followup of children with congenital left-to-right shunting.
However, the findings of the present study should be
carefully interpreted as their significance is limited by
the small cohort size, absence of longitudinal data, and
inability to use cardiac magnetic resonance imaging.
Another limiting factor was the fact that the adoption
of the La Farge formula for oxygen consumption in
the assessment of pulmonary blood flow (and vascular
resistance) was assessed by an indirect Fick method. This
may represent an important source of error, particularly
in patients younger than 2 years old (31). Further research
is needed to clarify the role of biomarkers and shear stress
in the development of PH during the clinical course of
congenital heart diseases.
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